Co-occurrence patterns of esophageal and stomach cancer across 204 countries and territories: a spatial correspondence and systematic analysis
Open Access
- 17 October 2025
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 15, 1613839
Abstract
Background: Esophageal and gastric cancers are common malignant tumors of the digestive tract worldwide, characterized by a substantial disease burden and significant regional disparities. While these cancers share anatomical proximity, risk factors, and pathogenic mechanisms to some extent, there remains a lack of comprehensive and up-to-date global comparative studies on their co-occurrence patterns and burden trends. Methods: Using primary data from the Global Burden of Disease (GBD) 2021 study, we defined and categorized global co-occurrence patterns of esophageal and gastric cancers based on quartile methods. Descriptive analysis, correlation analysis, age-period-cohort modeling, decomposition analysis, and predictive modeling were employed to thoroughly examine the disease burden of both cancers across 204 countries and territories from 1990 to 2021. Results: The disease burden of gastric cancer consistently exceeded that of esophageal cancer in most countries and regions. Spatially, the Eastern and Northern Hemispheres, including countries such as China and Mongolia, were identified as consistent high-burden regions for both cancers. In contrast, the Western and Southern Hemispheres were predominantly characterized by single-cancer dominance or low-burden patterns. Disease burden was negatively correlated with the Socio-demographic Index (SDI), with higher burden observed in low-SDI regions. Males and older populations faced elevated disease risks. Furthermore, population growth and aging were identified as major drivers increasing the overall burden. Predictions indicate that by 2031, the age-standardized rates of both cancers will continue to decline, yet the overall burden of gastric cancer will remain significantly higher than that of esophageal cancer. Conclusions: Gastric cancer imposes a heavier disease burden than esophageal cancer across most countries and regions. These findings underscore the necessity for sustained and targeted prevention strategies, such as the promotion of healthy lifestyles, enhanced early screening, and improved healthcare accessibility in high-burden regions, to effectively reduce the global burden of esophageal and gastric cancers.Keywords
This publication has 48 references indexed in Scilit:
- Global trends and epidemiological shifts in gastrointestinal cancers: insights from the past four decadesCancer Communications, 2025
- Cancer situation in China: an analysis based on the global epidemiological data released in 2024Cancer Communications, 2024
- Global, regional, and national burden of spinal cord injury from 1990 to 2021 and projections for 2050: A systematic analysis for the Global Burden of Disease 2021 studyAgeing Research Reviews, 2024
- Burden of Stomach Cancer Incidence, Mortality, Disability-Adjusted Life Years, and Risk Factors in 204 Countries, 1990–2019: An Examination of Global Burden of Disease 2019Journal of Gastrointestinal Cancer, 2024
- Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upAnnals of Oncology, 2022
- Global disease burden of COPD from 1990 to 2019 and prediction of future disease burden trend in ChinaPublic Health, 2022
- Cancer—Incidence, prevalence and mortality in the oldest-old. A comprehensive reviewMechanisms of Ageing and Development, 2017
- Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016JAMA Oncology, 2017
- Past and current trends in endoscopic diagnosis for early stage gastric cancer in JapanGastric Cancer, 2016
- Assessing Validity and Application Scope of the Intrinsic Estimator Approach to the Age-Period-Cohort ProblemDemography, 2013